Sentences with phrase «of vaccinology»

Shabir Madhi is Executive Director of the National Institute for Communicable Diseases, National Health Laboratory Service, Professor of Vaccinology; School of Pathology; University of Witwatersrand, and Co-director, University of Witwatersrand / MRC Respiratory and Meningeal Pathogens Research Unit.

The scientific work at the HZI Department of Vaccinology and Applied Microbiology includes the elucidation of mechanisms of host responses to infection and vaccination, discovering new mucosal adjuvants, and developing and validating vaccines against specific infectious diseases.

He is the Maurice R. Hilleman Professor of Vaccinology at the Perelman School of Medicine at the University of Pennsylvania.

Not exact matches

Kim Mulholland, a professor of child health and vaccinology at the London School of Hygiene and Tropical Medicine, says that although the low numbers are surprising and «quite disappointing», researchers should not necessarily rule out RTS, S.

Division of Infectious Diseases and Vaccinology, School of Public Health, University of California, Berkeley, CA, USA.

Division of Infectious Diseases and Vaccinology, School of Public Health, University of California, Berkeley, Berkeley, CA 94720 — 7360, USA.

This stands vaccinology on its head and raises all sorts of new complications for research.

Brad Spellberg's research interests are diverse, ranging from basic immunology and vaccinology, to pure clinical and outcomes research, to process improvement work related to delivery of care, focusing on safety net hospitals.

In the battle against multidrug resistance, the ideal way of preventing disease is a vaccine, and having a structure of BamE opens the door to a structural vaccinology approach.»

Division of Infectious Diseases and Vaccinology, School of Public Health, University of California, Berkeley, Berkeley, CA 94720 - 3370, USA.

However, substantial technological advances of the past decade, such as synthetic vaccinology and platform manufacturing, can expedite the process and shorten manufacturing time, allowing clinical evaluation to begin sooner, according to the authors.

The article was co-authored by leaders in HIV vaccinology, including Anthony S. Fauci, M.D., director of the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, and lead author Lawrence Corey, M.D., of the Fred Hutchinson Cancer Research Center.

«The whole world has been in urgent need of a serological method to distinguish dengue virus from Zika virus infections, and this the first to have such high sensitivity and specificity in dengue - endemic regions,» said Eva Harris, study co-author and UC Berkeley professor in the Division of Infectious Diseases and Vaccinology at the School of Public Health.

In the context of the «European Training Programme in Vaccinology «Fraunhofer IME will provide three different Training Modules including Assay Development and Validation, focused on SPR technology, Process Development and scale up, as well as on Requirements for GMP - production.

Kim et al. suggest that moving away from empirical research to either systems analysis or hypothesis driven approaches may advance our vaccinology understanding.5 Interrogation of peripheral blood responses following vaccination, termed «systems vaccinology», has led to the identification of immune signatures and pathways that are correlated to immune responses.

Systems analysis can extend further than vaccinology in immunosenescence research and, indeed, the emerging and exciting field of «immunomics» has vast potential for characterising age - associated alterations in immune function.

A specific focus of WBVR is research on infection biology, immunology and vaccinology of relevant veterinary and human, current and emerging infectious diseases.

E. Remarque: PhD in immunology and over 20 years of experience in vaccinology, focusing on how the immune system responds to polymorphic antigens.

Hypothesis driven approaches to vaccinology can utilise the knowledge gained from mechanistic mouse models and our molecular understanding of intrinsic defects to human cells.5 However, caution is required when extrapolating data from murine models, as there are substantial differences between immune ageing in mice and humans.6 Nevertheless, model systems and ex vivo analyses of molecular alterations in aged human cells have identified multiple changes in the vaccination response with age and the aged immune system in general.

The Jenner will provide 20 places on each of 3 courses: a) basic immunology, b) vaccine clinical development and biomanufacturing, and c) human and veterinary vaccinology.

Together the Institute Investigators comprise one of the largest non-profit sector research and development activities in vaccinology.

As a part of VIOLIN, we have developed Vaxign, the first web - based publically available vaccine target design tool based on bioinformatics analysis of genome sequences using the strategy of reverse vaccinology.

A key program of VIOLIN is Vaxign, the first web - based publically available vaccine target design tool based on bioinformatics analysis of genome sequences using the strategy of reverse vaccinology.

NIAID - LMIV, U.S. National Institute of Allergy and Infectious Diseases (NIAID)- Laboratory of Malaria Immunology and Vaccinology, USA

As AMA1 malaria vaccines are evaluated in efficacy trials, the impact of genetic diversity of parasite antigens on vaccine efficacy is likely to emerge as a critical problem requiring integration of methods and concepts drawn from molecular epidemiology, molecular evolution, immunology and structural vaccinology [9], [13].

iCubed seeks to make a strong impact in the fields of immunology, microbiology, and vaccinology both locally, in Rhode Island and beyond, by providing junior researchers with opportunities to learn from our institute's most skilled scientists.

The Laboratory of Malaria Immunology and Vaccinology (LMIV), U.S. National Institute of Allergy and Infectious Diseases (NIAID) has established a nonhuman primate model of placental malaria that for the first time reproduces all the features of P. falciparum malaria in pregnant women.

Trained as a physician, specialised in epidemiology, clinical pharmacology and vaccinology, Dr Odile Leroy has spent most of her carrier in vaccine development, as a scientist in Africa for nine years, as corporate clinical director of airborne vaccines for 10 years at Sanofi Pasteur.

Juhani Eskola's areas of expertise can be summarised as follows: Public health, Vaccinology, Immunology, pharmaceutical industry, Preclinical toxicology studies, Clinical trials.

He worked in various disciplines including vaccinology, immunology, stem cell biology, cellular signaling mechanisms, and monoclonal antibody therapy of tumors.

From 2005 to 2013 he was Head of Process Develoment at the Netherlands Vaccine Institute (NVI) and National Institute for Public Health and the Environment (RIVM)- Vaccinology.

Claude undertakes various responsibilities in the administration of research, including being a member of the Institut Pasteur Board of Directors and President of the Scientific Advisory Board of the Cochin - Pasteur Clinical Investigation Center in Vaccinology.

The VIM (Virology and Molecular Immunology) laboratory is located at the INRA centre of Jouy - en - Josas (close to Paris) and provides strong expertise in virology, biochemistry, immunology, vaccinology, dendritic cell biology, and genomics.

She has published over 250 articles and reviews, mainly in the areas of Infectious diseases, Immunology and Vaccinology.

For her research in immunology and vaccinology, Claude has received numerous awards and honors, and was nominated Chevalier of the Legion of Honour by the French Republic in 2008.

Claude Leclerc is Professor at the Institut Pasteur and Head of the Immune Regulation and Vaccinology Unit.

Eric has a Medical Doctorate (MD) from the University of Ouagadougou in 2010, followed by a diploma in vaccinology and courses / training in Good Clinical Practice, monitoring and evaluation, evaluation of malaria programmes and assessment and analysis of malaria indicators of the demographic and health surveys.

She has worked in vaccinology for 40 years, and has contributed to the development of synthetic adjuvants and peptidic vaccines and of several innovative delivery systems and cancer vaccines.